These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 30423575

  • 1. The Impact of the Opioid Antagonist Naloxone on Experimentally Induced Craving in Nicotine-Dependent Individuals.
    Krause D, Warnecke M, Schuetz CG, Soyka M, Manz KM, Proebstl L, Kamp F, Chrobok AI, Pogarell O, Koller G.
    Eur Addict Res; 2018; 24(5):255-265. PubMed ID: 30423575
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Withdrawal Symptoms and Nicotine Dependence Severity Predict Virtual Reality Craving in Cigarette-Deprived Smokers.
    Thompson-Lake DG, Cooper KN, Mahoney JJ, Bordnick PS, Salas R, Kosten TR, Dani JA, De La Garza R.
    Nicotine Tob Res; 2015 Jul; 17(7):796-802. PubMed ID: 25475087
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hypothalamic-pituitary-adrenal axis and sympatho-adreno-medullary responses during stress-induced and drug cue-induced cocaine craving states.
    Sinha R, Talih M, Malison R, Cooney N, Anderson GM, Kreek MJ.
    Psychopharmacology (Berl); 2003 Oct; 170(1):62-72. PubMed ID: 12845411
    [Abstract] [Full Text] [Related]

  • 8. An acute dose of nicotine enhances cue-induced cocaine craving.
    Reid MS, Mickalian JD, Delucchi KL, Hall SM, Berger SP.
    Drug Alcohol Depend; 1998 Jan 01; 49(2):95-104. PubMed ID: 9543646
    [Abstract] [Full Text] [Related]

  • 9. Nicotine effects and the endogenous opioid system.
    Kishioka S, Kiguchi N, Kobayashi Y, Saika F.
    J Pharmacol Sci; 2014 Jan 01; 125(2):117-24. PubMed ID: 24882143
    [Abstract] [Full Text] [Related]

  • 10. A randomized, double-blind, placebo-controlled study of the kappa opioid receptor antagonist, CERC-501, in a human laboratory model of smoking behavior.
    Jones JD, Babalonis S, Marcus R, Vince B, Kelsh D, Lofwall MR, Fraser H, Paterson B, Martinez S, Martinez DM, Nunes EV, Walsh SL, Comer SD.
    Addict Biol; 2020 Jul 01; 25(4):e12799. PubMed ID: 31240842
    [Abstract] [Full Text] [Related]

  • 11. Endogenous opioid tone in patients with rheumatoid arthritis.
    Kassimos D, Choy EH, Grossman AB, Chikanza IC, Panayi GS.
    Br J Rheumatol; 1996 May 01; 35(5):436-40. PubMed ID: 8646433
    [Abstract] [Full Text] [Related]

  • 12. Blunted opiate modulation of hypothalamic-pituitary-adrenocortical activity in men and women who smoke.
    al'Absi M, Wittmers LE, Hatsukami D, Westra R.
    Psychosom Med; 2008 Oct 01; 70(8):928-35. PubMed ID: 18799426
    [Abstract] [Full Text] [Related]

  • 13. Acute HPA axis response to naltrexone differs in female vs. male smokers.
    Roche DJ, Childs E, Epstein AM, King AC.
    Psychoneuroendocrinology; 2010 May 01; 35(4):596-606. PubMed ID: 19837518
    [Abstract] [Full Text] [Related]

  • 14. Diurnal effects of fluoxetine and naloxone on the human hypothalamic-pituitary-adrenal axis.
    Torpy DJ, Grice JE, Hockings GI, Walters MM, Crosbie GV, Jackson RV.
    Clin Exp Pharmacol Physiol; 1997 Jun 01; 24(6):421-3. PubMed ID: 9171947
    [Abstract] [Full Text] [Related]

  • 15. Effect of flumazenil on basal and naloxone-stimulated ACTH and cortisol release in humans.
    Torpy DJ, Jackson RV, Grice JE, Hockings GI, Crosbie GV, Walters MM.
    Clin Exp Pharmacol Physiol; 1994 Feb 01; 21(2):157-61. PubMed ID: 8039271
    [Abstract] [Full Text] [Related]

  • 16. Evidence of a disturbance of the hypothalamic-pituitary-adrenal axis in polycystic ovary syndrome: effect of naloxone.
    Lanzone A, Guido M, Ciampelli M, Fulghesu AM, Pavone V, Proto C, Caruso A, Mancuso S.
    Clin Endocrinol (Oxf); 1996 Jul 01; 45(1):73-7. PubMed ID: 8796141
    [Abstract] [Full Text] [Related]

  • 17. High-dose naloxone (1.0 mg/kg): psychological and endocrine effects in normal male subjects pretreated with one milligram of dexamethasone.
    Martín-Del-Campo AF, Cortés-Sotres J, Herrera-Ferrá K, Ulloa-Aguirre A.
    Psychoneuroendocrinology; 1998 May 01; 23(4):413-24. PubMed ID: 9695140
    [Abstract] [Full Text] [Related]

  • 18. The relationship between naloxone-induced cortisol and delta opioid receptor availability in mesolimbic structures is disrupted in alcohol-dependent subjects.
    Wand GS, Weerts EM, Kuwabara H, Wong DF, Xu X, McCaul ME.
    Addict Biol; 2013 Jan 01; 18(1):181-92. PubMed ID: 22264217
    [Abstract] [Full Text] [Related]

  • 19. Aspirin increases the human hypothalamic-pituitary-adrenal axis response to naloxone stimulation.
    Hockings GI, Grice JE, Crosbie GV, Walters MM, Jackson AJ, Jackson RV.
    J Clin Endocrinol Metab; 1993 Aug 01; 77(2):404-8. PubMed ID: 8393884
    [Abstract] [Full Text] [Related]

  • 20. Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.
    O'Malley SS, Krishnan-Sarin S, Farren C, Sinha R, Kreek MJ.
    Psychopharmacology (Berl); 2002 Feb 01; 160(1):19-29. PubMed ID: 11862370
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.